Zauatbayeva, G. ., Syzdykova , L., Keyer , V. ., Shustov , A., Abilmagzhanov , A., & Zhurynov , M. (2022). NUCLEOSIDE ANALOG FAVIPIRAVIR IS A POOR INHIBITOR AGAINST THE SARS-COV-2 VIRUS IN CELL CULTURE, BUT FAVIPIRAVIR IS HIGHLY ACTIVE AGAINST VENEZUELAN EQUINE ENCEPHALITIS VIRUS. Eurasian Journal of Applied Biotechnology, (2), 44–53. https://doi.org/10.11134/btp.2.2022.7